Pain Mgmt RN study materials
Pain Mgmt RN study resources

Anticoagulated and Scheduled for an Epidural Steroid Injection in Three Days

Pain Mgmt RN · Put your knowledge to work in context.

All case studies

Anticoagulated and Scheduled for an Epidural Steroid Injection in Three Days

Mr. L is 67 with a 5-month history of L4 radicular pain that has failed physical therapy and gabapentin. A fluoroscopy-guided L4-L5 transforaminal epidural steroid injection is scheduled in 3 days. Medications: apixaban 5 mg twice daily for atrial fibrillation (CHA2DS2-VASc 5), aspirin 81 mg daily, ibuprofen 600 mg every 8 hours most days, metformin 1000 mg twice daily, atorvastatin. Labs: eGFR 58, A1c 9.2%, platelets 210,000, INR 1.1. BMI 34. He says he cannot take time off work and asks to 'skip the blood thinner just for a couple of days.'

1. Does this patient proceed as scheduled? Identify what must be resolved before any needle enters the epidural space and who must be involved.

Read the worked answer

He should not proceed in 3 days on his current regimen without an explicit, coordinated plan. The default proceduralist error here is to let the patient 'self-manage' his apixaban, which produces an unverified hold.

Resolve before the needle:

  1. Who is prescribing the apixaban and what is the stroke risk? CHA2DS2-VASc 5 is a real annual stroke risk. The hold must be prescribed by the anticoagulation prescriber (or cardiology/primary care), documented with a start and stop date, not negotiated at the front desk.
  2. Confirm actual adherence and last dose - the last dose time must be verified by history and, where available, the pharmacy fill record. A patient who takes a dose 'sometimes' is not the same as one taking it twice daily.
  3. Timing: for apixaban and neuraxial procedures, plan a 72-hour interruption (three full days without drug) before the injection, with the procedure timed to that window - not 'two days.' Do not bridge with heparin; bridging increases bleeding without reducing stroke in this setting.
  4. Aspirin at 81 mg alone generally does not require stopping for a neuraxial injection. Ibuprofen should stop several days before, both for platelet effect and because he should not be on it chronically with eGFR 58.
  5. Renal function and dose criteria - recheck creatinine; apixaban dosing criteria depend on age, weight, and creatinine. Make sure the dose he is actually holding is the dose he is actually prescribed.
  6. Shared decision with documented risk/benefit - the alternative of continuing conservative care is legitimate and should be offered, especially with an A1c of 9.2% and a demanding work schedule.

Escalate to: prescribing clinician, the proceduralist, and the patient together, with the plan in writing and a confirmation call the day before.

2. Write the specific periprocedural medication instructions and the intra-procedural choices, with rationale for each.

Read the worked answer

Before the procedure

  • Apixaban: hold for 72 hours (last dose at least 3 days before), ordered by the prescriber; resume 24 hours after the injection if hemostasis is secure (longer if a larger needle or blood was encountered). No heparin bridging. Rationale: neuraxial bleeding is catastrophic and vertebral canal hematoma risk outweighs a 3-day interruption in a patient whose stroke risk is chronic, not acute.
  • Aspirin 81 mg: continue. Rationale: single-agent antiplatelet therapy is not a barrier to neuraxial injection, and stopping it adds cardiovascular risk without a proportionate bleeding benefit.
  • Ibuprofen: stop 4-5 days before and do not resume routinely; with eGFR 58 and concurrent apixaban it is the least defensible drug on his list.
  • Metformin: no contrast is planned for a fluoroscopic injection; no need to hold unless iodinated contrast is used.

During

  • Choose a non-particulate steroid (e.g., dexamethasone) rather than a particulate suspension such as methylprednisolone acetate. Rationale: transforaminal injection places drug near radicular arteries; particulate steroid has been associated with catastrophic spinal cord infarction. This is a judgment about route plus agent, not about efficacy alone.
  • Use live fluoroscopy with contrast to confirm needle position, and stop if vascular uptake is seen.

After

  • Glucose: expect a rise for 2-5 days in a patient with an A1c of 9.2%. Give him a written sick-day plan and ask him to check glucose at home if he has a meter; notify his diabetes clinician.
  • Neurologic checks: teach him to report new leg weakness, saddle numbness, or bowel/bladder change immediately - the same-day call, not the next appointment.
  • Counsel on expected timeline: steroid effect is typically days, and relief may be partial; plan the follow-up at 2-3 weeks to decide whether repeat injection is justified.

3. The patient says, 'Just skip the blood thinner for a couple of days - I can't take time off.' How do you respond, and what alternatives do you offer?

Read the worked answer

Respond with respect and specifics, not a policy recitation.

  • Acknowledge the constraint: 'Your job matters, and I want to find something that works with it.'
  • Explain the reason for 72 rather than 48 hours in concrete terms: the drug must be cleared enough that a needle near the spinal canal does not cause bleeding that could cost him the use of his legs. 'A couple of days' leaves measurable drug on board.
  • Correct the assumption that the hold is the risky part: the risky part is a partial hold that nobody verified, in a patient who then goes to work and lifts.

Alternatives to offer

  1. Schedule the injection at the start of a work week with a pre-arranged hold approved by his anticoagulation prescriber, and give him the exact last-dose and resume-dose times in writing.
  2. Reschedule to a date that fits his calendar rather than compressing the hold. Delay is safer than a truncated interruption.
  3. Optimize non-interventional care meanwhile - adjust gabapentin to a therapeutic dose, add a topical agent, refer to PT, address the ibuprofen and glucose. Many radicular pain patients improve enough in 4-6 weeks to reconsider the injection.
  4. Offer a shared-decision conversation with his cardiologist if he is worried about stroke risk, so the trade-off is made by the people who own each side of it.

Document the conversation, including that he was told the plan cannot proceed on a self-directed 48-hour hold.